| Literature DB >> 27781070 |
Jeries Jadoun1, Ahmad Yazbak1, Salwa Rushrush1, Amira Rudy2, Hassan Azaizeh3.
Abstract
Raphanus sativus L. (radish), a member of Brassicaceae, is widely used in traditional medicine in various cultures for treatment of several diseases and disorders associated with microbial infections. The antibacterial activity of the different plant parts has been mainly attributed to several isothiocyanate (ITC) compounds. However, the low correlation between the ITC content and antibacterial activity suggests the involvement of other unknown compounds. The objective of this study was to investigate the antibacterial potential of red radish seeds and identify the active compounds. A crude ethanol seed extract was prepared and its antibacterial activity was tested against five medically important bacteria. The ethanol extract significantly inhibited the growth of all tested strains. However, the inhibitory effect was more pronounced against Streptococcus pyogenes and Escherichia coli. Bioassay-guided fractionation of the ethanol extract followed by HPLC, 1H-NMR, 13C-NMR, 15N-NMR, and HMBC analysis revealed that the active fraction consisted of a single new compound identified as [5-methylsulfinyl-1-(4-methylsulfinyl-but-3-enyl)-pent-4-enylidene]-sulfamic acid, which consisted of two identical sulfur side chains similar to those found in ITCs. The minimal inhibitory concentration values of the isolated compound were in the range of 0.5-1 mg/mL. These results further highlight the role of radish as a rich source of antibacterial compounds.Entities:
Year: 2016 PMID: 27781070 PMCID: PMC5066007 DOI: 10.1155/2016/9271285
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Antibacterial activity of radish seed ethanol extract tested against pathogenic bacteria, using the agar well diffusion method. Each value is the mean ± standard deviation of three replicates.
| Pathogenic bacteria | Inhibition zone (mm)a | |
|---|---|---|
| Extractb | Chloramphenicol (10 mg/mL)c | |
|
| 20 ± 2 | 30 ± 2 |
|
| 11 ± 2 | 15 ± 1 |
|
| 19 ± 0 | 27 ± 2 |
|
| 9 ± 2 | 16 ± 3 |
|
| 16 ± 3 | 29 ± 2 |
aInhibitory zones in mm, including diameter of the well (6.0 mm); mean ± standard deviation of three replicates.
bThe concentration of the extract was 130–200 mg/mL; 70–80 μL was added to each well.
c15 μL was added to each well.
Antibacterial activity of seed extract fractions tested against E. coli determined by the agar well diffusion method. Each value is the mean ± standard deviation of three replicates.
| Fraction (10 mg/wella) | Inhibition zone (mm)b |
|---|---|
| Ethyl acetate | 27 ± 2 |
| Hexane | 12.5 ± 1 |
| Water (remaining fraction) | — |
| Chloramphenicolc | 27 ± 2 |
a10 mg of dried extract was dissolved in 100 μL of 15% methanol and the whole volume added to the well. —: no inhibition.
bInhibitory zones in mm, including diameter of the well (6.0 mm).
c15 μL of 10 mg/mL was added to each well.
Antibacterial activity tested against E. coli of the eight ethyl acetate fractions separated using silica gel column chromatography and determined using the agar well diffusion method. Each value is the mean ± standard deviation from three replicates.
| Fraction (2 mg/wella) | Inhibition zone (mm)b |
|---|---|
| Fraction 1 | 22 ± 1 |
| Fraction 2 | 26 ± 1 |
| Fractions 3–8 | — |
| Chloramphenicolc | 27 ± 2 |
a2 mg of dried fraction was dissolved in 100 μL of 15% methanol and the whole volume added to the well.
bInhibitory zones in mm, including diameter of the well (6.0 mm). —: no inhibition.
c15 μL of 10 mg/mL was added to each well.
Figure 1Proposed chemical structure of the active compound of fraction 2. (a) Sulfur-containing chain [4-(methylsulfinyl)but-3-enyl moiety] of the active compound. (b) Determined full structure of the active compound.
Figure 2Description of retrosynthesis proposed for MSPSA. The amine 2 can give the sulfamic acid 1 by reacting the amine with sulfamic acid. This amine can be prepared from compound 3. X in compound 3 represents leaving group like halogen. The coupling of the monomer 4 with another monomer gives the dimer 3.
Antibacterial activity of fraction 2 tested against various pathogenic bacteria. Each value is the mean ± standard deviation of three replicates.
| Bacteria | Inhibition zone (mm)a | MIC (mg/mL) | ||
|---|---|---|---|---|
| MSPSA fraction (2 mg/well)b | Chloramphenicol (0.16 mg/well) | MSPSA fraction | Chloramphenicol | |
|
| 13 ± 2 | 15 ± 2 | 1 | 0.0625 |
|
| 13 ± 2 | 15 ± 1 | 0.5 | 0.0625 |
|
| 25 ± 2 | 29 ± 2 | 0.5 | 0.0078 |
|
| 15 ± 1 | 15 ± 1 | 1 | 0.0625 |
|
| 19 ± 2 | 27 ± 2 | 0.5 | 0.0078 |
a2 mg of dried fraction was dissolved in 100 μL of 15% methanol and the whole volume was added to the well.
bInhibitory zones in mm, including diameter of the well (6.0 mm).